| Literature DB >> 36119640 |
Ding-Yun Feng1, Jian-Xia Zhou1, Xia Li1, Wen-Bin Wu1, Yu-Qi Zhou1, Tian-Tuo Zhang1.
Abstract
Purpose: Acinetobacter baumannii is the most common microorganism in sputum cultures from long-term hospitalized patients and is often the cause of hospital-acquired pneumonia (HAP), which is usually associated with poor prognosis and high mortality. It is sometimes difficult to distinguish between A. baumannii infection and colonization. This study aimed to evaluate factors that differentiate infection from colonization and predict mortality in patients with nosocomial pneumonia caused by A. baumannii. Patients andEntities:
Keywords: Acinetobacter baumannii; colonization; drug resistance; infection; mortality
Year: 2022 PMID: 36119640 PMCID: PMC9480586 DOI: 10.2147/IDR.S377480
Source DB: PubMed Journal: Infect Drug Resist ISSN: 1178-6973 Impact factor: 4.177
Figure 1The flow chart of this study.
Significant Univariate and Multivariate Logistic Regression Analyses of Predictors Used to Distinguish Between Infection and Colonization
| Characteristics | Infection n=571(80.0%) | Colonization n=143(20.0%) | Univariate | Multivariate | ||||
|---|---|---|---|---|---|---|---|---|
| OR | 95%Cl | P | OR | 95%Cl | P | |||
| Gender: male | 436(76.4%) | 107(74.8%) | 1.087 | 0.711–1.661 | 0.701 | |||
| Age, y | 60.1±17.55 | 56.62±18.04 | 1.011 | 1.001–1.021 | 0.036 | 1.011 | 1.000–1.022 | 0.047 |
| Smoke | 166(29.1%) | 33(23.1%) | 1.366 | 0.89–2.098 | 0.154 | |||
| ICU admission | 243(42.6%) | 33(23.1%) | 2.47 | 1.618–3.769 | <0.001 | 1.091 | 0.521–2.284 | 0.818 |
| Total number of inpatient departments | 1.68±0.77 | 1.36±0.61 | 2.006 | 1.478–2.724 | <0.001 | 1.763 | 1.053–2.950 | 0.031 |
| Charlson score | 2.61±1.64 | 2.39±1.58 | 1.089 | 0.969–1.224 | 0.152 | |||
| WBC, median(interquartile range), *10e9/L | 9.05(7.23) | 7.695(5.155) | 1.042 | 1.009–1.077 | 0.012 | 1.004 | 0.972–1.037 | 0.82 |
| N, median(interquartile range), *10e9/L | 7.05(6.06) | 5.43(4.05) | 1.102 | 1.051–1.157 | <0.001 | 1.068 | 1.006–1.134 | 0.031 |
| L<0.8*10e9/L | 325(56.9%) | 91(63.6%) | 0.755 | 0.517–1.013 | 0.146 | |||
| NLR ratio, median(interquartile range) | 11.77(36.47) | 10.91(27.96) | 1.002 | 0.999–1.004 | 0.146 | |||
| BUN/ALB, median(interquartile range) | 0.218(0.229) | 0.182(0.164) | 3.109 | 1.228–7.871 | 0.017 | 1.011 | 0.435–2.353 | 0.979 |
| PCT, median(interquartile range), ng/mL | 0.28(0.906) | 0.117(0.34) | 1.019 | 0.984–1.057 | 0.291 | |||
| CRP, median(interquartile range), mg/L | 32.5(67.96) | 15.5(36.45) | 1.01 | 1.006–1.015 | <0.001 | 1.007 | 1.002–1.012 | 0.005 |
| MDR pathogens | 389(68.1%) | 89(62.2%) | 1.297 | 0.886–1.899 | 0.181 | |||
Notes: Data were presented by median (interquartile range), numbers (percentage), or mean ± standard deviation (x±s) (continuous). Continuous variables were compared using Student’s t-test or Mann–Whitney U-test and categorical variables using Pearson’s chi-square or Fisher’s exact probability test. P-value<0.05 is considered significant.
Abbreviations: ICU admission, intensive care unit admission; WBC, white blood cell; N, absolute value of neutrophil; L, absolute value of lymphocyte; NLR ratio, Neutrophils/lymphocytes ratio; BUN/ALB, blood urea nitrogen/albumin; PCT, procalcitonin; CRP, C-reactive protein; MDR pathogens, multidrug resistant pathogens.
Figure 2Comparison of different receiver-operating characteristics curves for predicting infection or colonization model.
Significant Univariate and Multivariate Logistic Regression Analyses of Predictors for Hospital-Acquired Pneumonia in-Hospital Mortality
| Characteristics | Related mortality n=117 | Survival n=454 | Univariate | Multivariate | ||||
|---|---|---|---|---|---|---|---|---|
| OR | 95%Cl | P | OR | 95%Cl | P | |||
| Gender: male | 93(79.5%) | 343(75.6%) | 1.254 | 0.763–2.062 | 0.372 | |||
| Age, y | 57.20±17.98 | 60.85±17.38 | 0.988 | 0.977–1.000 | 0.046 | 0.974 | 0.960–0.988 | <0.001 |
| Smoke | 30(25.6%) | 136(30.0%) | 0.806 | 0.508–1.279 | 0.36 | |||
| ICU admission | 65(55.6%) | 178(39.2%) | 1.938 | 1.286–2.922 | 0.002 | 1.215 | 0.566–2.607 | 0.617 |
| Total number of inpatient departments | 1.80±0.83 | 1.64±0.75 | 1.298 | 1.006–1.674 | 0.045 | 0.897 | 0.551–1.462 | 0.664 |
| Charlson score | 3.34±1.42 | 2.42±1.64 | 1.391 | 1.229–1.574 | <0.001 | 1.352 | 1.172–1.561 | <0.001 |
| WBC, median(interquartile range), *10e9/L | 10.97(6.48) | 8.79(7.13) | 1.019 | 0.995–1.043 | 0.123 | |||
| N, median(interquartile range), *10e9/L | 9.16(6.11) | 6.64(5.47) | 1.073 | 1.034–1.113 | <0.001 | 1.013 | 0.970–1.057 | 0.561 |
| L<0.8*10e9/L | 75(64.1%) | 250(55.1%)) | 1.457 | 0.957–2.219 | 0.079 | |||
| NLR ratio, median(interquartile range) | 19.23(58.05) | 10.63(29.86) | 1.003 | 1.002–1.005 | <0.001 | 1.002 | 1.001–1.004 | 0.008 |
| BUN/ALB, median(interquartile range) | 0.35(0.36) | 0.19(0.20) | 10.233 | 4.799–21.823 | <0.001 | 5.783 | 2.543–13.151 | <0.001 |
| PCT, median(interquartile range), ng/mL | 0.95(3.43) | 0.20(0.53) | 1.042 | 1.013–1.073 | 0.005 | 1.008 | 0.984–1.032 | 0.52 |
| CRP, median(interquartile range), mg/L | 69.0(93.9) | 27.5(56.13) | 1.011 | 1.007–1.014 | <0.001 | 1.006 | 1.002–1.010 | 0.004 |
| MDR pathogens | 98(83.8%) | 291(64.1%) | 2.889 | 1.705–4.896 | <0.001 | 1.900 | 1.043–3.463 | 0.036 |
| CPIS≥6 | 105(89.7%) | 303(66.7%) | 4.361 | 2.326–8.174 | <0.001 | 2.352 | 1.115–4.959 | 0.025 |
Notes: Data were presented by median (interquartile range), numbers (percentage), or mean ± standard deviation (x±s) (continuous). Continuous variables were compared using Student’s t-test or Mann–Whitney U-test and categorical variables using Pearson’s chi-square or Fisher’s exact probability test. P-value<0.05 is considered significant.
Abbreviations: ICU, admission intensive care unit admission; WBC, white blood cell; N, absolute value of neutrophil; L, absolute value of lymphocyte; NLR ratio, Neutrophils/lymphocytes ratio; BUN/ALB, blood urea nitrogen/albumin; PCT, procalcitonin; CRP, C-reactive protein; MDR pathogens, multidrug resistant pathogens; CPIS, Clinical Pulmonary for Infection Score.
Figure 3Analysis of receiver-operating characteristics curve for predicting mortality model.
The Drug Resistance of a.baumannii Infection Group of Hospital-Acquired Pneumonia
| Antibiotic | Cases | Percent |
|---|---|---|
| CFZ | 571 | 100.00 |
| CTR | 564 | 98.77 |
| CXM | 410 | 71.80 |
| IMP | 369 | 64.62 |
| CIP | 368 | 64.45 |
| MER | 364 | 63.75 |
| SAM | 362 | 63.40 |
| CFM | 360 | 63.05 |
| CEF | 359 | 62.87 |
| CTX | 359 | 62.87 |
| LEV | 358 | 62.70 |
| GEN | 353 | 61.82 |
| AMC | 340 | 59.54 |
| SXT | 300 | 52.54 |
| TAZ | 264 | 46.23 |
| TGC | 2 | 0.35 |
Abbreviations: HAP, hospital-acquired pneumonia; CFZ, cefazolin; CTR, ceftriaxone; CXM, cefuroxime; IMP, imipenem; CIP, ciprofloxacin; MER, meropenem; SAM, ampicillin sulbactam; CFM, cefepime; CEF, ceftazidime; CTX, cefotaxime; LEV, levofloxacin; GEN, gentamicin; AMC, amikacin; SXT, Cotrimoxazole; TAZ, piperacillin/tazobactam; TGC, tigecycline.